Synthesis of 4-substituted-3-aminopiperidin-2-ones: Application to the synthesis of a conformationally constrained tetrapeptide N-acetyl-Ser-Asp-Lys- Pro

Journal of Organic Chemistry

Volumn 70, Issue 15, 2005, Pages 5946-5953

  Kumar, Sukeerthi ^a   Flamant Robin, Céline ^a   Wang, Qian ^a   Chiaroni, Angèle ^a   Sasaki, N André ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; AMINO ACIDS; CONFORMATIONS; COPPER COMPOUNDS; ESTERS; SYNTHESIS (CHEMICAL);

DIASTEREOSELECTIVE ADDITION; LACTAM-BRIDGED DIPEPTIDES; RACEMIZATION-FREE REDUCTIVE AMINATION; TETRAPEPTIDES;

KETONES;

3 AMINO 4 VINYLPIPERIDIN 2 ONE; 3 AMINOPIPERIDIN 2 ONE; DIPEPTIDE; ESTER; LACTAM; N ACTYLSERYLASPARTYLLYSYLPROLINE; PIPERIDINE DERIVATIVE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; METHODOLOGY; PEPTIDE SYNTHESIS; PROTEIN CONFORMATION; RACEMIZATION; REDUCTION; STEREOCHEMISTRY;

AMINATION; BRIDGED COMPOUNDS; LACTAMS; MODELS, CHEMICAL; OLIGOPEPTIDES; OXIDATION-REDUCTION; PIPERIDONES; STEREOISOMERISM;

EID: 22244444458     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo050736k     Document Type: Article

References (66)

1. (a) Olson, G. L.; Bolin, D. R.; Bonner, M. P.; Bos, M.; Cook, C. M.; Fry, D. C.; Graves, B. J.; Hatada, M.; Hill, D. E.; Kahn, M.; Madison, V. S.; Rusiecki, V. K.; Sarabu, R.; Sepinwall, J.; Vincent, G. P.; Voss, M. E. J. Med. Chem. 1993, 3039-3049.
2. (b) Hruby, V. J. Life Sci. 1982, 31, 189.
3. (c) Hruby, V. J.; Al-Obeidi, F.; Kazmierski, W. Biochem. J. 1990, 268, 249.
4. (d) Giannis, A.; Kolter, T. Angew. Chem., Int. Ed. Engl. 1993, 32, 1244-1267.
5. (e) Gante, J. Angew. Chem., Int. Ed. Engl. 1994, 33, 1699-1720.
6. (f) Liskamp, R. M. J. Recl. Trav. Chim. Pays-Bas 1994, 113, 1-19.
7. (a) Hruby, V. J. Nat. Rev. Drug Design 2002, 1, 847.
8. (b) Nagai, U.; Sato, K. Tetrahedron Lett. 1985, 26, 647.
9. (c) Nagai, U.; Sato, K.; Nakamura, R.; Kato, R. Tetrahedron 1993, 49, 3577.
10. (a) Hanessian, S.; Smith-MacNaughton, G.; Lambort, H. G.; Lubell, W. D. Tetrahedron 1993, 53, 12789.
11. (b) Halab, L.; Gosselin, F.; Lubell, W. D. Biopolymers, Pept. Sci. 2000, 55, 101.
12. (a) Freidinger, R. M.; Veber, D. F.; Perlow, D. S.; Brooks, J. R.; Saperstein, R. Science 1980, 210, 656-658.
13. (b) Freidinger, R. M.; Perlow, D.; Veber, D. F. J. Org. Chem. 1982, 47, 104-109.
14. (c) Veber, D. F.; Freidinger, R. M. Trends Neurosci. 1985, 392-396.
15. (d) Freidinger, R. M. In Peptide: Synthesis, Structure, Function; Rich, D. H., Gross, E., Eds.; Pierce Chemical Co.: Rockford, IL, 1981; pp 673-683.
16. (e) Freidinger, R. M. J. Med.Chem. 2003, 46, 1-14.
17. (a) Samanen, J.; Hempel, J. C.; Narindary, D.; Regoli, D. In Chemistry and Bilogy: Proceedings of the Tenth American Peptide Symposium; Marshall, G. R., Ed.; ESCOM: Leiden, The Netherlands, 1988; pp 123-125.
18. (b) Samanen, J.; Cash, T.; Narindray, D.; Brandeis, E.; Adams, W., Jr.; Weideman, H.; Yellin, T. J. Med. Chem. 1991, 34, 3036-3043.
19. (c) Ede, N.; Rale, I. D.; Hearn, M. T. W. Tetrahedron Lett. 1990, 31, 6071-6074.
20. (a) Wolfe, M. S.; Dutta, D.; Aube, J. J. Org. Chem. 1997, 62, 654-663.
21. Ref 6 cited in (b) Zydowky, T. M.; Dellaria, J. F., Jr.; Nellans, H. N. J. Org. Chem. 1988, 53, 5607-5616.
22. (c) Wolf, J.-P.; Rapoport, H. J. Org. Chem. 1989, 54, 3164-3173.
23. (d) Rodriguez, R.; Estiarte, M. A.; Diez, A.; Rubiralta, M.; Colell, A.; Garcia-Ruiz, C.; Fernandes-C, J. C. Tetrahedron 1996, 52, 7727-7736.
24. (e) Rodriguez, R.; Deiz, A.; Rubiralta, M.; Giralta, E. Heterocycles 1996, 43, 513-517.
25. (f) Estiarte, M. A.; de Souza, M. V. N.; Diez, A. Tetrahedron 1999, 55, 10173-10186.
26. (g) Estiarte, M. A.; Diez, A.; Rubiralta, M.; Jackson, R. F. W. Tetrahedron 2001, 57, 157-161.
27. (h) Piro, J.; Rubiralta, M.; Giralta, E.; Diez, A. Tetrahedron Lett. 2001, 42, 871-873.
28. (i) Koulocheri, S. D.; Magiatis, P.; Haroutounian, S. A. J. Org. Chem. 2001, 66, 7915-7918.
29. (j) De Borggraeve, W. M.; Rombouts, F. J. R.; Van der Eycken, E. V.; Toppet, S. M.; Hoornaert, G. J. Tetrahedron Lett. 2001, 42, 5693-5695.
30. (k) Hoffmann, T.; Waibel, R.; Gmeiner, P. J. Org. Chem. 2003, 68, 62-69.
31. (l) Tanaka, K.; Nemoto, H.; Sawanishi, H. Tetrahedron: Asymmetry 2005, 16, 809-815.
32. (m) de Laszlo, S. E.; Bush, B. L.; Doyle, J. J.; Greenlee, W. J.; Hangauer, D. G.; Halgren, T. A.; Lynch, R. J.; Schorn, T. W.; Siegl, P. K. S. J. Med. Chem. 1992, 35, 833-846.
33. (n) Rodriguez, R.; Vinets, I.; Diez, A.; Rubiralta, M. Synth. Commun. 1996, 26, 3029-3059.
34. (o) Weber, K.; Ohnmacht, U.; Gmeiner, P. J. Org. Chem. 2000, 65, 7406-7416.
35. (p) Piro, J.; Forns, P.; Blanchet, J.; Bonin, M.; Micouin, L.; Diez, A. Tetrahedron: Asymmetry 2002, 13, 995-1004.
36. Preliminary result dealing with the synthesis of 3-amino-4- methylpiperdin-2-one has been published. Flamant-Robin, C.; Wang, Q.; Sasaki, N. A. Tetrahedron Lett. 2001, 42, 8483-8484.
37. (a) Reetz, M. T. Angew. Chem., Int. Ed. Engl. 1991, 30, 1531-1546.
38. (b) Reetz, M. T. Chem. Rev. 1999, 1121-1162.
39. (c) Hanessian S.; Sumi, K. Synthesis 1991, 1083-1089.
40. (d) Hanessian S.; Wang, W.; Gai, Y. Tetrahedron Lett. 1996, 37, 7477-7480.
41. Han, G.; Hruby, V. J. Tetrahedron Lett. 2001, 42, 4281-4283.
42. Flamant-Robin, C.; Wang, Q.; Chiaroni, A.; Sasaki, N. A. Tetrahedron 2002, 58, 10475-10484.
43. Lenfant, M.; Wdzieczak-Bakala, J.; Guittet, E.; Prome, J.-C.; Sotty, D.; Frindel, E. Proc. Natl Acad. Sci. U.S.A. 1989, 86, 779-782.
44. (a) Pradelles, P.; Frobert, Y.; Créminon, C.; Ivonine, H.; Frindel, E. FEBS Lett. 1991, 289, 171-175.
45. (b) Pradelles, P.; Frobert, Y.; Créminon, C.; Liozon, E.; Massé, A.; Frindel, E. Biochem. Biophys. Res. Commun. 1990, 170, 986-993.
46. (a) Guigon, M.; Bonnet, D.; Lemoine, F.; et al. Exp. Hematol. 1990, 18, 1112-1115.
47. (b) Bonnet, D.; Lemoine, F. M.; Pontvert-Delucq, S.; Baillou, C.; Najman, A.; Guigon, M. Blood 1993, 82, 3307-3314.
48. (c) Cashman, J. D.; Eaves, A. C.; Eaves, C. J. Blood 1994, 84, 1534-1542.
49. (d) Jackson, J. D.; Yan, Y.; Ewel, C.; Talmage, J. E. Exp. Hematol. 1996, 24, 475-481.
50. (e) Rousseau-Plasse, A.; Lenfant, M.; Potier, P. Bioorg. Med. Chem. Lett. 1996, 4, 1113-1119.
51. (f) Thierry, J.; Grillon, C.; Gaudron, S.; Potier, P.; Riches, A.; Wdzieczak-Bakala, J. J. Pept. Sci. 2001, 284-293.
52. (a) Masse, A.; Ramirez, L. H.; Bindoula, G.; et al. Blood 1998, 91, 441-449.
53. (b) Bogden, A. E.; Moreau, J. P.; Gamba-Vitalo, C.; et al. Int. J. Cancer 1998, 76, 38-46.
54. (c) Aidoudi, S.; Guigon, M.; Drouet, V.; Caen, J. P.; Han, J. C. Int. J. Hematol. 1996, 68, 145-155.
55. (d) Watanabe, T.; Brown, G. S.; Kelsey, L. S. Exp. Hematol. 1996, 24, 713-721.
56. (a) Grillon, C.; Reiger, K.; Bakala, J.; et al. FEBS Lett. 1990, 274, 30-34.
57. (b) Wdzieczak-Bakala, J.; Fache, M.-P.; Lenfant, M.; et al. Leukemia 1990, 4, 235-237.
58. (c) Cavasin, M. A.; Rhaleb N-E.; Yang, X.-P.; Carretero O. A. Hypertension 2004, 43, 1140-1145.
59. (a) Hanesworth, J. M.; Sardinia, M. F.; Krebs, L. T.; Hall, K. L.; Harding, J. W. J. Pharmacol. Exp. Ther. 1993, 266, 1036-1042.
60. (b) Azizi, M.; Rousseau, A.; Ezan, E.; et al. J. Clin. Invest. 1996, 97, 839-844.
61. (c) Rousseau, A.; Michaud, A.; Chauvet, M.-T.; et al. J. Biol. Chem. 1995, 270, 3656-3661.
62. Aziz, M.; Ezan, E.; et al. Hypertension 1997, 30, 1015-1019.
63. (a) Liu, J.-M.; Lawrence, F.; Kovacevic, M.; Bignon, J.; Papadimitriou, E.; Lallemand, J. Y.; Katsoris, P.; Potier, P.; Fromes, Y.; Wdzieczak-Bakala, J. Blood 2003, 101, 3014-3020.
64. (b) Wang, D.; Carretero, O. A.; Yang, X.-Y.; Rhaleb, N.-E.; Liu, Y.-H.; Liao, T.-D.; Yang, X.-P. Am. J. Physiol.: Heart Circ. Physiol. 2004, 287, H2099-H2105.
65. Beyermann, M.; Bienert, M.; Niedrich, H. J. Org. Chem. 1990, 55, 721-728.
66. Carlsen, P. H.; Katsuki, T.; Martin, V. S.; Sharpless, K. B. J. Org. Chem. 1981, 46, 3936-3938.